Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Study of Ganetespib + Docetaxel vs Docetaxel in Advanced NSCLC Adenocarcinoma
2012-004349-34Phase 3Terminated
- Sponsor
- Synta Pharmaceuticals Corp.
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ganetespib in Non-small cell lung cancer adenocarcinoma (NSCLC), sponsored by Synta Pharmaceuticals Corp.. Started Jan 2013; status: terminated.
02
Drugs
ganetespib
03
Conditions
Non-small cell lung cancer adenocarcinoma (NSCLC)
Beyond the preview
Go deeper on 2012-004349-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004349-34.